Is a complete FRA/BM8 research report available?

No complete published report is available for fra/BM8 (FRA/BM8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/BM8 (FRA/BM8)

Frankfurt Stock Exchange: FRA/BM8 · EUR

€56.9

-0.20 (-0.3%)· Recorded snapshot

Market cap	11.1B
Revenue (ttm)	3B
Net income (ttm)	63.9M
EPS (ttm)	€0.33
P/E (trailing)	173.5x
P/E (forward)	10.5x
Volume	171

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): 63.9M
EPS (ttm): €0.33
P/E (trailing): 173.5x
P/E (forward): 10.5x
Market cap: 11.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/BM8 indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	3,221
Employees Change	-361%
Employees Change Percent	-10.61
Enterprise value	EUR 13.9B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US09061G1013
Last refreshed	2026-09-09
Market cap	EUR 11.1B
Price	EUR 56.92
Price currency	EUR
Rev Per Employee	925,740.22x
Sector	Healthcare
Sector PE	38.03
Sector PE Fwd	14.34
Sic	2836
Symbol	fra/BM8
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.58%
EV Earnings	218.34x
EV/EBIT	32.43x
EV/EBITDA	24.73x
EV/FCF	21.58x
EV/Sales	4.76x
FCF yield	5.83%
Forward P/E	10.48x
P/B ratio	2x
P/E ratio	173.5x
P/S ratio	3.72x
PE Ratio10 Y	135.19x
PE Ratio3 Y	60.01x
PE Ratio5 Y	157.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.67%
EBITDA Margin	18.94%
FCF margin	22.03%
Gross margin	50.97%
Gross Profit	EUR 1.5B
Gross Profit Growth	-1.29%
Gross Profit Growth Q	15.11%
Gross Profit Growth3 Y	18.44%
Gross Profit Growth5 Y	18.57%
Net Income	EUR 63.9M
Net Income Growth	-88.9%
Net Income Growth Q	-81.39%
Net Income Growth Qo Q	-57.58%
Net Income Growth3 Y	-9.97%
Net Income Growth5 Y	-38.61%
Pretax Margin	4.38%
Profit Margin	2.14%
Profit Per Employee	EUR 19,830
ROA	3.26
Roa5y	2.28
ROCE	4.97
ROE	1.18
Roe5y	3.83
ROIC	3.24
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.05%
Cagr15y	7.26%
Cagr1y	17.64%
Cagr20y	7.91%
Cagr3y	-12.25%
Cagr5y	-3.08%
EPS Growth	-88.85
EPS Growth Q	-81.3
EPS Growth Qo Q	-57.65
EPS Growth3 Y	-10.29
EPS Growth5 Y	-38.77
FCF Growth	6.23%
FCF Growth Q	-17.17%
FCF Growth Qo Q	-30.26%
FCF Growth3 Y	144.98%
FCF Growth5 Y	33.6%
OCF Growth	11.78%
OCF Growth Q	-9.26%
OCF Growth Qo Q	-23.81%
OCF Growth3 Y	74.52%
OCF Growth5 Y	26.07%
Revenue Growth	11.2x
Revenue Growth Q	19.91x
Revenue Growth Qo Q	29.17x
Revenue Growth3 Y	15.09x
Revenue Growth5 Y	12.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.36
Assets	EUR 10.3B
Cash	EUR 765M
Current Assets	EUR 3.4B
Current Liabilities	EUR 1.4B
Debt	EUR 3.7B
Debt EBITDA	EUR 6.41
Debt Equity	EUR 0.66
Debt FCF	EUR 5.69
Equity	EUR 5.5B
Interest Coverage	5.98
Liabilities	EUR 4.7B
Long Term Assets	EUR 6.8B
Long Term Liabilities	EUR 3.3B
Net Cash	EUR -2.9B
Net Cash By Market Cap	EUR -26.29
Net Debt EBITDA	EUR 5.16
Net Debt Equity	EUR 0.53
Net Debt FCF	EUR 4.51
Tangible Book Value	EUR 688.5M
Tangible Book Value Per Share	EUR 3.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Inventory Turnover	1.07
Net Working Capital	EUR 1.8B
Quick ratio	1.16
Working Capital	EUR 2B
Working Capital Turnover	EUR 1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-33.84%
1Y total return	17.63%
200-day SMA	49.63
3Y total return	-32.45%
50-day SMA	54.32
50-day SMA vs 200-day SMA	50over200
5Y total return	-14.46%
All Time High	140.5
All Time High Change	-59.5%
All Time High Date	2015-07-20
All Time Low	3.02
All Time Low Change	1,784.77%
All Time Low Date	2004-11-05
ATR	0.97
Ch YTD	12.18
High	56.92
High52	60.74
High52 Date	2026-08-13
High52ch	-6.29%
Low	56.92
Low52	42.62
Low52 Date	2026-05-19
Low52ch	33.55%
Ma50ch	4.78%
Price vs 200-day SMA	14.7%
RSI	54.74
RSI Monthly	50.58
RSI Weekly	64.57
Sharpe ratio	0.58x
Sharpe Ratio3y	-0.31x
Sharpe Ratio5y	-0.04x
Sortino ratio	1.15
Sortino Ratio3y	-0.28
Sortino Ratio5y	0.11
Total Return	-0.61%
Tr YTD	12.18
Tr15y	186.1%
Tr1m	10.31%
Tr1w	2.63%
Tr3m	17.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,410,440%
Net Borrowing	3,143,128,150
Shares Insiders	0.52%
Shares Institutions	101.49%
Shares Qo Q	-1.62%
Shares Yo Y	0.61%
Short Ratio	5.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 457.7M
Adjusted OCF	561,731,653
Average Volume	74.7x
Bv Per Share	28.59
CAPEX	EUR -104.1M
Ch10y	-33.84
Ch15y	186.1
Ch1m	10.31
Ch1w	2.63
Ch1y	17.63
Ch20y	357.9
Ch3m	17.39
Ch3y	-32.45
Ch5y	-14.46
Ch6m	9.29
Change	-0.35%
Change From Open	0
Close	57.12
Days Gap	-0.35
Depreciation Amortization	125,358,284.2
Dollar Volume	9,733.3
Earnings Date	2026-10-27
EBIT	EUR 437.4M
EBITDA	EUR 564.8M
EPS	EUR 0.33
F Score	4
FCF	EUR 646.1M
FCF EV Yield	4.63x
Financing CF	3,109,533,886
Fiscal Year End	December
Founded	1,996
Goodwill	564,682,347.6
Graham Number	14.48415
Graham Upside	-74.55
Income Tax	EUR 66.6M
Investing CF	-4,157,467,554
Is Primary Listing	0
Last Earnings Date	2026-08-06
Last Report Date	2026-06-30
Lynch Fair Value	EUR 1.64
Lynch Upside	-97.12
Ma150	50.26
Ma150ch	13.26%
Ma20	57.4
Ma20ch	-0.84%
Net CF	-297,436,568
Next Earnings Date	2026-10-27
Open	56.92
P FCF Ratio	17.15
P FCF Ratio SBC	24.21
P OCF Ratio	14.77
P OCF Ratio SBC	19.73
Ppne	852,514,523.2
Price Date	2026-09-08
Price EBITDA	EUR 19.62
Ptbv Ratio	16.1
Relative Volume	2.29x
Revenue	2,981,809,234x
SBC By Revenue	6.32x
Share Based Comp	188,478,349
Tax By Revenue	2.24x
Tax Rate	51.06%
Tr20y	357.92%
Tr6m	9.29%
Volume	171
Z Score	1.9

FRA/BM8 (FRA/BM8)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/BM8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/BM8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on FRA/BM8

Frequently asked questions